Our advisors are a group of leading experts in Neuroscience, Cardiology, Drug Discovery and Development, as well as Drug Delivery and Business.

Advisory Board


Scientific Advisory Board


Helen M. Burt, PhD, CAHS, OC

Angiotech Professor of drug delivery, UBC Faculty of Pharmaceutical Sciences. Former Director, Research for Angiotech Pharmaceuticals Inc. Expert in development of polymer-based drug delivery systems for controlled and localized drug delivery.


John Cairns, MD, FRCPC, FRCP (Lond.), FCAHS, FACC

Professor, Medicine, UBC Division of Cardiology. Principal investigator of multiple clinical trials for major pharma companies, e.g. AstraZeneca, Sanofi and Genentech. Chaired Steering Committees of numerous cardiovascular clinical trials.


Ron Petersen, PhD, MD

Professor of Neurology and Cora Kanow Professor of Alzheimer's Disease Research. Director, Mayo Alzheimer's Disease Research Center, Mayo Clinic. Co-director, Clinical Core for the Alzheimer's Disease Neuroimaging Initiative. In 2021, Dr Petersen was given the Lifetime Achievement Award for Alzheimer's Disease Therapeutic Research. He has authored over 1000 peer-reviewed articles on memory disorders, aging, and Alzheimer's disease.

Business Advisory Board


Peng Wang, PhD

Led discovery and development of over 30 new drug candidates in US and China. Among them, Reslizumab, Cinquil™ has been launched globally and Sanbexin™ has been launched in China.


William Wei-Guo Jia, MSc, PhD

Company co-founder. Associate Professor, Department of Surgery, UBC. Founder and Chief Scientific Officer of several high-tech companies, including Panagin Pharmaceuticals, Pepmetric Biotech Inc. and ViroGin Biotech.


Leadership Team ] [ Advisory Board ]